Mi SciELO
Servicios Personalizados
Articulo
Indicadores
Citado por SciELO
Links relacionados
Similares en SciELO
Compartir
Revista Habanera de Ciencias Médicas
versión On-line ISSN 1729-519X
Resumen
GIRALT-HERRERA, Alejandro; ROJAS-VELAZQUEZ, Jesús Miguel y LEIVA-ENRIQUEZ, Jessica. Relationship between COVID-19 and Hypertension. Rev haban cienc méd [online]. 2020, vol.19, n.2 Epub 22-Abr-2020. ISSN 1729-519X.
Introduction:
The first three months of 2020 have been influenced by the spreading of a pandemic caused by the SARS-coronavirus 2, which causes COVID-19 infection that in some cases is associated with acute respiratory distress syndrome.
Objective:
To identify the relationship between COVID-19 and hypertension.
Material and Methods:
A bibliographic review was carried out using database search engines. In addition, reference literature in Cardiology was used as well as information from official government websites such as WHO/PAHO and other scientific societies.
Development:
Coronaviruses enter into target cells through a spike S protein, whose S1 surface unit is coupled to the angiotensin-converting enzyme 2 as a receptor. In the different revised series, the clear relationship between the history of arterial hypertension and the unfavorable evolution is observed in patients with COVID-19. In an extensive literature search, there is no scientific evidence for discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in hypertensive patients with COVID-19.
Conclusions:
The angiotensin-converting enzyme acts as a SARS-CoV2 receptor. Hypertensive individuals have a less favorable evolution course of the condition caused by this virus. Discontinuation of treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers is not advisable in hypertensive patients with COVID-19.
Palabras clave : COVID-19; SARS-CoV 2; 2019-Ncov; SARS; coronavirus; hypertension.